ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Genfleet Therapeutics (Shanghai) Inc. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 23 studies whose lead sponsor is Genfleet Therapeutics (Shanghai) Inc. or one of 2 companies grouped under it. 14 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 16, 2026.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

Compare Genfleet Therapeutics (Shanghai) with Otsuka and Qilu Pharmaceutical →

Pipeline: 3 programs

Each counted once: 3 with a study Genfleet Therapeutics (Shanghai) Inc. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Genfleet Therapeutics (Shanghai) Inc.’s own registered studies; Genfleet Therapeutics (Shanghai) Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Genfleet Therapeutics (Shanghai) Inc.’s studies test, most open studies first — 10 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

6 of Genfleet Therapeutics (Shanghai) Inc.’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. 1A
  7. M
  8. 1J
  9. 2J
  10. A
  11. S
  12. O
  13. 1N

Add all 6 to your calendar (.ics) → With an account.

All 23 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1461%Recruiting 10 · Not yet recruiting 4
  • Completed626%
  • Stopped early313%

Phase

  • Phase 216
  • Phase 115
  • Phase 33

Where

  • China15
  • Australia3
  • Italy1
  • Greece1
  • Spain1
  • United States1

Over the years

  1. 19
  2. 20
  3. 21
  4. 22
  5. 23
  6. 24
  7. 25
  8. 726

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Genfleet Therapeutics (Shanghai) Inc.

  • Genfleet Therapeutics (Shanghai) Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    18 studies
  • Zhejiang Genfleet Therapeutics Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • GenFleet Therapeutics (Australia) Pty Ltd.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Studies

Recruiting first, then most recently updated. Showing 23 of 23.